CYP — Cynata Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$4.02m
- AU$3.12m
- AU$0.08m
Annual cashflow statement for Cynata Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.113 | -10.8 | -6.71 | -5.16 | -3.7 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.3 | -14.3 | -9.96 | -8.72 | -6.74 |
| Capital Expenditures | — | — | — | -0.05 | 0 |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | — | — | -0.05 | 0 |
| Financing Cash Flow Items | 0.21 | -0.318 | 0 | -0.522 | -0.121 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.21 | 6.72 | 0 | 7.61 | 2.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.92 | -7.63 | -9.96 | -1.16 | -4.15 |